The MarketWatch News Department was not involved in the creation of this content. San Jose, CA, June 04, 2025 (GLOBE NEWSWIRE) -- Node AI, the decentralized AI ...
Hosted on MSN
Sentinel lymph node biopsy may be safely omitted in some patients with early-stage breast cancer: Phase III trial
Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback